Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction
Study of OPTIMIZER System in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)
Sponsor: Impulse Dynamics, Inc
Enrolling: Male and Female Patients
IRB Number: AAAT9371
U.S. Govt. ID: NCT05855135
Contact: Esteban Ceballos: / ec3539@cumc.columbia.edu
Additional Study Information: You may want to join this study because your heart condition may respond to a device-based therapy called cardiac modulation therapy, CCM therapy, called the OPTIMIZER System.
Investigator
Hirad Yarmohammadi, MD, MPH
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with Heart Failure with Reduced Ejection Fraction (HFrEF)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Esteban Ceballos
ec3539@cumc.columbia.edu

This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE